Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 216.00
+2.00 (0.93%)
Apr 2, 2026, 1:30 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 56.77 billion as of April 2, 2026. Its market cap has decreased by -17.88% in one year.
Market Cap
56.77B
Enterprise Value
96.50B
Revenue
20.51B
Ranking
n/a
PE Ratio
11.97
Stock Price
216.00
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 56.77B, an increase of 517.88%. That is a compound annual growth rate of 16.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 56.77B | -23.72% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 222.70B |
| Bora Pharmaceuticals | 55.75B |
| Center Laboratories | 30.23B |
| TTY Biopharm Company | 18.10B |
| Grape King Bio | 17.92B |
| ScinoPharm Taiwan | 16.37B |
| Synmosa Biopharma | 15.67B |
| YungShin Global Holding | 14.41B |